Ethics and neuropsychiatric genetics: A review of major issues

International Journal of Neuropsychopharmacology

Volumn 15, Issue 10, 2012, Pages 1547-1557

  Hoge, Steven K ^a   Appelbaum, Paul S ^a  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

Consent; ethics; genetics

Indexed keywords

ADULTHOOD; ATTITUDE TO ILLNESS; CHILD BEHAVIOR; FAMILY FUNCTIONING; GENE EXPRESSION PROFILING; GENETIC COUNSELING; GENETIC SCREENING; HEALTH CARE POLICY; HISTORY; HUMAN; INFORMED CONSENT; KNOWLEDGE; MEDICAL ETHICS; MEDICAL GENETICS; MEDICAL RESEARCH; MENTAL DISEASE; NEUROPSYCHIATRY; PATIENT DECISION MAKING; PHARMACOGENOMICS; POLITICS; PRENATAL SCREENING; PRIORITY JOURNAL; RESEARCH SUBJECT; RESPONSIBILITY; REVIEW; SELF CONCEPT; SOCIAL DISCRIMINATION; SOCIOECONOMICS; STIGMA;

GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INFORMED CONSENT; MENTAL DISORDERS; NEUROPSYCHIATRY;

EID: 84867267196     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001982     Document Type: Review

References (94)

1. American Board of Genetic Counseling (2011). (http://www.abgc.net/ABGC/ AmericanBoardofGenetic Counselors.asp). Accessed 9 January 2012.
2. American College of Obstetricians and Gynecologists Committee on Genetics (2010). ACOG Committee Opinion No. 469: carrier screening for fragile X syndrome. Obstetrics and Gynecology 116, 1008-1010.
3. Appelbaum PS (2010). Genetic discrimination in mental disorders : the impact of GINA. Psychiatric Services 61, 338-340.
4. Arranz MJ, Kapur S (2008). Pharmacogenetics in psychiatry: are we ready for widespread clinical use? Schizophrenia Bulletin 34, 1130-1144.
5. Ashley EA, Gutte AJ, Wheeler MT, Chen R, et al. (2010). Clinical assessment incorporating a personal genome. Lancet 375, 1525-1535.
6. Austin JC, Honer WG (2007). The genomic era and serious mental illness : a potential application for psychiatric genetic counseling. Psychiatric Services 58, 254-261.
7. Baars MJH, Henneman L, ten Kate LP (2005). Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians : a global problem. Genetics in Medicine 7, 605-610.
8. Bashford A, Levine P (2010). The Oxford Handbook of the History of Eugenics. New York: Oxford University Press.
9. Bassett AS, Chow EWC, AbdelMalik P, Gheorghiu M, et al. (2003). The schizophrenia phenotype in 22q11 deletion syndrome. American Journal of Psychiatry 160, 1580-1586.
10. Bates BR, Lynch JA, Bevan JL, Condit CM (2005). Warranted concerns, warranted outlooks: a focus group study of public understandings of genetic research. Social Science and Medicine 60, 331-344.
11. Beach SRH, Brody GH, Gunter TD, Packer H, et al. (2010). Child maltreatment moderates the association of MAOA with symptoms of depression and antisocial personality disorder. Journal of Family Psychology 24, 12-20.
12. Biesecker BB, Peay HL (2003). Ethical issues in psychiatric genetics research: points to consider. Psychopharmacology (Berlin) 171, 27-35.
13. Black E (2008). War against the Weak: Eugenics and America's Campaign to Create a Master Race. New York: Dialog Press.
14. Bredenoord AL, Kroes HY, Cuppen E, Parker M, et al. (2011). Disclosure of individual genetic data to research participants : the debate reconsidered. Trends in Genetics 27, 41-47.
15. Burke W, Pinsky LE, Press NA (2001). Categorizing tests to identify their ethical, legal, and social implications. American Journal of Medical Genetics 106, 233-240.
16. Caspi A, McClay J, Moffitt TE, Mill J, et al. (2002). Role of genotype in the cycle of violence in maltreated children. Science 297, 851-854.
17. Caspi A, Sugden K, Moffitt TE, Taylor A, et al. (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389.
18. Clark A (1994). The Genetic Testing of Children : Report of a Working Party of the Clinical Genetics Society. London: Clinical Genetics Society.
19. Chiu RWK, R, Zheng YWL, Leung TY, Sun H, et al. (2011). Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. British Medical Journal 342, c7401.
20. Delisi LE, Bertisch H (2006). A preliminary comparison of the hopes of researchers, clinicians, and families for the future ethical use of genetic findings on schizophrenia. American Journal of Medical Genetics 141B, 110-115.
21. Dugan RB, Wiesner GL, Juengst ET, O'Riordan M, et al. (2003). Duty to warn at-risk relatives for genetic disease : genetic counselors' clinical experience. American Journal of Genetics, Part C Seminars in Medical Genetics 119, 27-34.
22. Duncan LE, Keller MC (2011). A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry. American Journal of Psychiatry 168, 1041-1049.
23. Fabsitz RR, McGuire A, Sharp RR, Puggal M, et al. (2010). Ethical and practical guidelines for reporting genetic research results to study participants. Circulation : Cardiovascular Genetics 3, 574-580.
24. Faraone SV, Tsuang MT, Tsuang DW (1999). Genetics of Mental Disorders : A Guide for Students, Clinicians, and Researchers. New York: Guilford.
25. Finn CT, Smoller JW (2006). Genetic counseling in psychiatry. Harvard Review of Psychiatry 14, 109-121.
26. Finn CT, Wilcox MA, Korf BR, Blacker D, et al. (2005). Psychiatric genetics : a survey of psychiatrists ' knowledge, opinions, and practice patterns. Journal of Clinical Psychiatry 66, 821-830.
27. Galton F (1883). Inquiries into Human Faculty and its Development. London: Macmillan.
28. Garber KB, Visootsak J, Warran ST (2008). Fragile X syndrome. European Journal of Human Genetics 16, 666-672.
29. Goldman JS, Farmer JM, Van Deerlin VM, Wilhelmsen KC, et al. (2004). Frontotemporal dementia : genetics and genetic counseling dilemmas. Neurologist 10, 227-234.
30. Goldman JS, Hahn SE, Catania JW, LaRusse-Eckert S, et al. (2011). ACMG Practice Guidelines: Genetic counseling and testing for Alzheimer disease : joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genetics in Medicine 13, 597-605.
31. Gollust SE, Hull SC, Wilfond BS (2002). Limitations of direct-to-consumer advertising for clinical genetic testing. Journal of the American Medical Association 288, 1762-1767.
32. Greely HT (2001). Informed consent and other ethical issues in human population genetics. Annual Review of Genetics 35, 785-800.
33. Greely HT (2011). Get ready for the flood of fetal gene screening. Nature 469, 289-291.
34. Green RC, Roberts S, Cupples LA, Relkin et al. (2009). Disclosure of APOE genotype for risk of Alzheimer's disease. New England Journal of Medicine 361, 245-254.
35. Hassenfeld IN (2002). Doctor-patient relationships in Nazi Germany and the fate of psychiatric patients. Psychiatric Quarterly 73, 183-194.
36. Hodgkinson KA, Murphy J, O'Neill S, Brzustowicz L, et al. (2001). Genetic counseling for schizophrenia in the era of molecular genetics. Canadian Journal of Psychiatry 46, 123-130.
37. Hoop JG, Savla G, Roberts LW, Zisook S, Dunn LB (2010). The current state of genetics training in psychiatric residency: views of 235 educators and trainees. Academic Psychiatry 34, 109-114.
38. Hogarth S, Javitt G, Melzer D (2008). The current landscape for direct-to-consumer genetic testing : legal, ethical, and policy issues. Annual Review of Genomics and Human Genetics 9, 161-182.
39. Jones I, Scourfield J, McCandless F, Craddock N (2002). Attitudes towards future testing for bipolar disorder susceptibility genes: a preliminary investigation. Journal of Affective Disorders 71, 189-193.
40. Kass L (2004). Life, Liberty, and the Defense of Dignity: The Challenge for Bioethics. New York: Encounter Books.
41. Kendler KS (2006). 'A gene for' The nature of gene action in psychiatric disorders. American Journal of Psychiatry 162, 1243-1252.
42. Kendler KS, Baker JH (2007). Genetic influences on measures of the environment : a systematic review. Psychological Medicine 37, 615-626.
43. Kim Y, Zerwas S, Trace SE, Sullivan PF (2011). Schizophrenia genetics : where next? Schizophrenia Bulletin 37, 456-463.
44. Klitzman R (2006). Questions, complexities, and limitations in disclosing individual genetic results. American Journal of Bioethics 6, 34-36.
45. Klitzman R (2010a). Exclusion of genetic information from the medical record : ethical and medical dilemmas. Journal of the American Medical Association 304, 1120-1121.
46. Klitzman R (2010b). Misunderstandings concerning genetics among patients confronting genetic disease. Journal of Genetic Counseling 19, 430-446.
47. Klitzman R, Appelbaum PS, Chung W, Sauer MV (2008). Anticipating issues related to increasing pre-implantation genetic diagnosis use : a research agenda. Reproductive Biomedicine Online 17 (Suppl. 1), 33-42.
48. Lawrence RE, Appelbaum PS (2011). Genetic testing in psychiatry : a review of attitudes and beliefs. Psychiatry 74, 315-331.
49. Leehey M (2009). Fragile X-associated tremor/ataxia syndrome: clinical phenotype, diagnosis, and treatment. Journal of Investigative Medicine 57, 830-836.
50. Lehmann LS, Weeks JC, Klar N, Biener L, et al. (2000). Disclosure of familial genetic information: perceptions of the duty to inform. American Journal of Medicine 109, 705-711.
51. Lo YM, Chan KC, Sun H, Chen EZ, et al. (2010). Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Science Translational Medicine 2, 61ra91.
52. McGowan PO, Sasaki A, D'Alessio AC, Dymov S, et al. (2009). Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nature Neuroscience 12, 342-348.
53. McGuire AL, Caulfield T, Cho MK (2008). Research ethics and the challenge of whole-genome sequencing. Nature Reviews Genetics 9, 152-156.
54. Marteau TM, Croyle RT (1998). The new genetics : psychological responses to genetic testing. British Medical Journal 316, 693-696.
55. Meiser B, Kasparian NA, Mitchell PB, Strong K, et al. (2008). Attitudes to genetic testing in families with multiple cases of bipolar disorder. Genetic Testing 12, 233-244.
56. Menasha JD, Schechter C, Willner J (2000). Genetic testing : a physician's perspective. Mt Sinai Journal of Medicine 67, 144-151.
57. Meyer J-E (1988). The fate of the mentally ill in Germany during the Third Reich. Psychological Medicine 18, 575-581.
58. Miller DT, Adam MP, Aradhya S, Biesecker LG, et al. (2010). Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. American Journal of Human Genetics 86, 749-764.
59. Milner KK, Collins EE, Connors GR, Petty EM (1998). Attitudes of young adults to prenatal screening and genetic correction for human attributes and psychiatric conditions. American Journal of Medical Genetics 76, 111-119.
60. Murphy KC (2002). Schizophrenia and velo-cardio-facial syndrome. Lancet 359, 426-430.
61. Murphy J, Scott J, Kaufman D, Geller G, et al. (2008). Public expectations for return of results from large-cohort genetic research. American Journal of Bioethics 8, 36-43.
62. Munafo MR, Currant C, Lewis G, Flint J (2009). Generenvironment interactions at the serotonin transporter locus. Biological Psychiatry 65, 211-219.
63. National Bioethics Advisory Commission (1999). Research Involving Human Biological Materials : Ethical Issues and Policy Guidance. Rockville, MD: National Bioethics Advisory Commission.
64. National Human Genome Research Institute (2010). NHGRI Policy Recommendations on Research Privacy Guidelines (http://www.genome.gov/11510216). Accessed 9 January 2012.
65. National Human Genome Research Institute (2011). NHGRI funds return of results studies, forms expert consortium (http://www.genome.gov/27545526). Accessed 9 January 2012.
66. Netzer C, Biller-Andorno N (2004). Pharmacogenetic testing, informed consent and the problem of secondary information. Bioethics 18, 344-360.
67. Nieminen T, Kähönen M, Viiri LE, Grönroos P, et al. (2008). Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease. Pharmacogenomics 9, 1475-1486.
68. Nuffield Council on Bioethics (1998). Mental Disorders and Genetics : The Ethical Context. West Sussex, UK: RPM Reprographics.
69. Ottman R, Hirose S, Jain S, Lerche H, et al. (2010). Genetic testing in the epilepsies-Report of the ILAE Genetics Commission. Epilepsia 51, 655-670.
70. Pasche B, Absher D (2011). Whole-genome sequencing a step closer to personalized medicine. Journal of the American Medical Association 305, 1596-1597.
71. Phelan J (2005). Geneticization of deviant behavior and consequences for stigma: the case of mental illness. Journal of Health and Social Behavior 46, 307-322.
72. Plomin R, Davis OS (2009). The future of genetics in psychology and psychiatry: microarrays, genome-wide association, and non-coding RNA. Journal of Child Psychology and Psychiatry, and Allied Disciplines 50, 63-71.
73. Richardson HS (2008). Incidental findings and ancillary-care obligations. Journal of Law, Medicine and Ethics 36, 256-270.
74. Rothstein MA (2010). Is deidentification sufficient to protect health privacy in research? American Journal of Bioethics 10, 3-11.
75. Smith LB, Sapers B, Reus VI, Freimer NB (1996). Attitudes towards bipolar disorder and predictive genetic testing among patients and providers. Journal of Medical Ethics 33, 544-549.
76. Sullivan J (2002). State will admit sterilization past. Portland Oregonian 15 November.
77. Tam GWC, Redon R, Carter NP, Grant SGN (2009). The role of DNA copy number variation in schizophrenia. Biological Psychiatry 66, 1005-1012.
78. Tarini BA, Singer D, Clark SJ, Davis MM (2009). Parents' interest in predictive genetic testing for their children when a disease has no treatment. Pediatrics 124, e432-e438.
79. Thapar A, Harold G, Rice F, Langley K, et al. (2007). The contribution of gene-environment interaction to psychopathology. Development and Psychopathology 19, 989-1004.
80. Torrey EF, Yolken R (2010). Psychiatric genocide: Nazi attempts to eradicate schizophrenia. Schizophrenia Bulletin 36, 26-32.
81. Trippitelli CL, Jamison KR, Folstein MF, Bartko JJ, et al. (1998). Pilot study on patients' and spouses' attitudes toward potential genetic testing for bipolar disorder. American Journal of Psychiatry 155, 899-904.
82. United States Government Accountability Office (2010). Direct-to-consumer genetic tests : misleading test results are further complicated by deceptive marketing and other questionable practices. GAO-10-847T July 22. (http://www.gao.gov/products/GAO-10-847T). Accessed 9 January 2012.
83. United States Huntington's Disease Genetic Testing Group (2003). Genetic testing for Huntington's disease : its relevance and implications (rev.). Huntington's Disease Society of America. (http://www.hdsa.org/images/content/1/ 1/11884.pdf). Accessed 9 January 2012.
84. Vassos E, Collier DA, Holden S, Patch C, et al. (2010). Penetrance for copy number variants associated with schizophrenia. Human Molecular Genetics 19, 3477-3481.
85. Verghese PB, Castellano JM, Holtzman DM (2011). Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurology 10, 241-252.
86. Walsh T, McClellan JM, McCarthy SE, Addington AM, et al. (2008). Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320, 539-543.
87. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, et al. (2004). Epigenetic programming by maternal behavior. Nature Neuroscience 7, 847-854.
88. Wendler D, Emanuel E (2002). The debate over research on stored biological samples: what do sources think? Archives of Internal Medicine 162, 1457-1462.
89. Wilde A, Meiser B, Mitchell PB, Hadzi-Pavlovic et al. (2011). Community interest in predictive genetic testing for susceptibility to major depressive disorder in a large national sample. Psychological Medicine 41, 1605-1613.
90. Wilhelm K, Meiser B, Mitchell PB, Finch AW, et al. (2009). Issues concerning feedback about genetic testing and risk of depression. British Journal of Psychiatry 194, 404-410.
91. Wilke RA, Dolan ME (2011). Genetics and variable drug response. Journal of the American Medical Association 306, 306-307.
92. Winner JG, Goebert D, Matsu C, Mrazek DA (2010). Training in psychiatric genomics during residency : a new challenge. Academic Psychiatry 34, 115-118.
93. Wolf SM, Lawrenz FP, Nelson CA, Kahn JP, et al. (2008). Managing incidental findings in human subjects research : analysis and recommendations. Journal of Law, Medicine and Ethics 36, 219-248.
94. Zick CD, Mathews CJ, Roberts JS, Cook-Deegan R, et al. (2005). Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior. Health Affairs (Millwood) 24, 483-490.